Hepatitis B virus in transfusion medicine: Still a problem?

Biologicals

Volumn 40, Issue 3, 2012, Pages 180-186

  Allain, Jean Pierre ^a   Candotti, Daniel ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood donors; HBV; Hepatitis B virus; OBI; Occult HBV infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; NUCLEIC ACID; VIRUS RNA;

BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; FALSE NEGATIVE RESULT; GENE MUTATION; GENOTYPE; GENOTYPE C; GENOTYPE E; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE SYSTEM; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SCREENING TEST; VIRUS IDENTIFICATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; GENETIC TESTING; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 84860619940     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.09.014     Document Type: Review

References (55)

1. Chu C.J., Hussain M., Lok A.S. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002, 122:1756-1762.
2. Cui C., Shi J., Hui L., Xi H., Zhuoma, Quni, et al. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 2002, 83:2773-2777.
3. Yu H., Yuan Q., Ge S.X., Wang H.Y., Zhang Y.L., Chen Q.R., et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I" PLoS ONE 2010, 5. e9297.
4. Xu L., Wei Y., Chen T., Lu J., Zhu C.L., Ni Z., et al. Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination. Vaccine 2010, 28:5986-5992.
5. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
6. Huang C.F., Dai C.Y., Chuang W.L., Ho C.K., Wu T.C., Hou N.J., et al. HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study. Prev Med 2009, 48:397-400.
7. Stramer S., Wend U., Candotti D., Forster G., Hollinger B., Dodd R., et al. Occurrence and characterization of naturally acquired hepatitis B infection among vaccinated blood donors. N Engl J Med 2011, 364:236-247.
8. Liu C.J., Chen D.S., Chen P.J. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006, 36:S33-S44.
9. Chaudhuri V., Tayal R., Nayak B., Achyarya S.K., Panda S.K. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004, 127:1356-1371.
10. Yuen M.F., Wong D.K.H., Lee C.K., Tanaka Y., Allain J.P., Fung J., et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis 2011, 52:624-632.
11. Zheng X., Ye X., Zhang L., Wang W., Shuai L., Wang A., et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 2011, 49:1730-1737.
12. Satake M., Taira R., Yugi H., Hino S., Kanemitsu K., Ikeda H., et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007, 47:1197-1205.
13. Su T.H., Chen P.J., Chen T.C., Cheng H.R., Li L., Lin K.S., et al. The clinical significance of occult hepatitis B transfusion in Taiwan - a look back study. Transfus Med 2010, 21:33-41.
14. Wang J.T., Lee C.Z., Chen P.J., Wang T.H., Chen D.S. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002, 42:1592-1597.
15. Fedorchenko S.V., Znevskaia L.I., Burma N.M., Borisevich T.E., Iurchenko L.F., Martynovich T.L. Latent HBV infection in single blood donors. Vopr Virusol 2008, 53:23-25.
16. Kaminski G., Alnaqdy A., Al-Belushi I.U., Nogrates J., Al-Dhahry S.H. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study. Med Princ Pract 2006, 15:368-372.
17. Bhatti F.A., Ullah Z., Salamat N., Ayub M., Ghani E. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007, 47:74-79.
18. Sofian M., Aghakhani A., Izadi N., Banifazi M., Kalantar E., Eslamifar A., et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2009, 14:308-312.
19. Behzad-Behbahani A., Mafi-Nejad A., Tabei S.Z., Lankarani K.B., Torab A., Moaddeb A. Anti-HBc and HBV DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 2006, 123:37-42.
20. Utama A., Octavia T.I., Dhenni R., Miskad U.A., Yusuf I., Tai S. Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J 2009, 6:128-136.
21. Seo D.H., Whang D.H., Song E.Y., Kim H.S., Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion 2011, [epub].
22. Murokawa H., Yoshikawa A., Ohnuma H., Iwata A., Katoh N., Miyamoto M., et al. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 2005, 88:10-16.
23. Mine H., Emura H., Miyamoto M., Tomono T., Mineshigi K., Murokawa H., et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003, 112:145-151.
24. Dhawan H.K., Marwhaha N., Sharma R.S., Chawla Y., Thakrai B., Saluja K., et al. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008, 14:5327-5330.
25. Panigrahi R., Biswas A., Datta S., Banerjee A., Chandra P.K., Mahaprta P.K., et al. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J 2010, 7:204-210.
26. Asim M., Ali R., Khan L.A., Husain S.A., Singla R., Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res 2010, 132:312-317.
27. Makroo R.N., Choudhury N., Jagannathan L., Parihar-Malhotra M., Raina V., Chaudhary R.K., et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 and hepatitis B&C viruses in Indian blood donors. Indian J Med Res 2008, 127:140-147.
28. Chaudhuri V., Nanu A., Panda A.K., Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003, 43:1442-1448.
29. Phikulsod S., Oota S., Tirawatnapong T., Sakuldamrongpanich T., Chalermchan W., Louisirirotchanakul S., et al. One-year experience of nucleic acid technology testing human immunodeficiency virus type a, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009, 49:1126-1135.
30. Louisirirotchanakul S., Oota S., Khuponsarb K., Chalermchan W., Phikulsod S., Chongkolwatana V., et al. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011, [epub].
31. Nantachit N., Thaikruea L., Thongsawat S., Leetrakool N., Fongsatikul L., Sompan P., et al. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007, 47:1803-1808.
32. Yang M.H., Li L., Hung Y.S., Hung C.H., Allain J.P., Lin K.S., et al. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion 2010, 50:65-74.
33. Li L., Chen P.J., Chen M.H., Chak K.F., Lin K.S., Lin-Tsai S.J. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008, 48:1198-1206.
34. Yuan Q., Ou S.H., Chen C.R., Ge S.X., Pei B., Chen Q.R., et al. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010, 48:357-362.
35. Shang G., Yan Y., Yang B., Shao C., Wang F., Li Q., et al. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Transfus Apher Sci 2009, 41:3-7.
36. Liu Y., Li P., Li C., Zhou J., Wu C., Zhou Y.H. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J 2010, 7:193-198.
37. Yuen M.F., Lee C.K., Wong D.K.H., Fung J., Hung I., Hsu A., et al. Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut 2010, 59:1389-1393.
38. Thedja M.D., Roui M., Harahap A.R., Siregar N.C., Ie S.I., Muljono D.H. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int 2010, 4:608-614.
39. Candotti D., Grabarczyk P., Ghiazza P., Roig R., Casamitjana N., Iudicone P., et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008, 49:537-547.
40. El Chaar M., Candotti D., Crowthers R.A., Allain J.P. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult Hepatitis B virus infection. Hepatology 2010, 52:1600-1610.
41. Zahn A., Li C., Danso K., Candotti D., Owusu-Ofori S., Temple J., et al. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008, 89:409-418.
42. Allain J.P., Belkhiri D., Vermeulen M., Crookes R., Cable R., Amiri A., et al. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009, 90:1868-1876.
43. Fang Y., Teng X., Xu W.Z., Zhao H.W., Fu L.J., Zhang F.M., et al. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol 2009, 81:826-835.
44. Cox L.E., Arslan O., Allain J.P. Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. J Med Virol 2011, 83:1321-1325.
45. Gunther S., Sommer G., Iwanska W., Will H. Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 1997, 238:363-371.
46. Soussan P., Garreau F., Zylberberg H., Ferray C., Brechot C., Kremsdorf D. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000, 105:55-60.
47. Mancini-Bourgine M., Bayard F., Soussan P., Deng Q., Lone Y.C., Kremsdorf D., et al. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol 2007, 81:4963-4972.
48. Hass M., Hannoun C., Kalinina T., Sommer G., Manegold C., Günther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005, 42:93-103.
49. Candotti D., Danso K., Allain J.P. Maternofetal transmission of hepatitis B virus genotype E in Ghana, West Africa. J Gen Virol 2007, 88:2686-2695.
50. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51:798-809.
51. Candotti D., El Chaar M., Allain J.P. Transfusion transmission of hepatitis B virus: still learning more about it. ISBT Sci Ser Vox Sang 2011, 6:234-240.
52. Kleinman S.H., Lelie N., Busch M.P. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009, 49:2454-2489.
53. Power J.P., El Chaar M., Temple J., Thomas M., Spillane D., Candotti D., et al. HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted hepatitis B virus. J Hepatol 2010, 53:780-787.
54. Levicnik-Stezinar S., Rahne-Potokar U., Candotti D., Lelie N., Allain J.P. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008, 48:1022-1025.
55. Candotti, et al., submitted for publication.